Histological changes in the liver of diabetic rats: A review of pathogenesis of nonalcoholic fatty liver disease in type 1 diabetes mellitus

References

• Adewole, S. O., & Ojewole, J. A. (2007). Artocarpus communis Forst. Root-bark aqueous extract- and strepto-zotocin-induced ultrastructural and metabolic changes in hepatic tissues of wistar rats. African Journal of Traditional, Complementary and Alternative Medicines, 4, 397–410.
   Google Scholar
• Ahmadieh, H., & Azar, S. T. (2014). Liver disease and diabetes: Association, pathophysiology, and management. Diabetes Research and Clinical Practice, 104, 53–62.10.1016/j.diabres.2014.01.003
   Google Scholar
• Alberti, K. G. M., & Zimmet, P. (2013). Epidemiology: Global burden of disease—where does diabetes mellitus fit in? Nature Reviews Endocrinology, 9, 258–260.10.1038/nrendo.2013.54
   Google Scholar
• Baquer, N. Z., Gupta, D., & Raju, J. (1998). Regulation of metabolic pathways in liver and kidney during experimental diabetes: Effects of antidiabetic compounds. Indian Journal of Clinical Biochemistry, 13, 63–80.10.1007/BF02867866
   Google Scholar
• Browning, J. D., & Horton, J. D. (2004). Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation, 114, 147–152.10.1172/JCI200422422
   Google Scholar
• Can, B., Ulusu, N. N., Kilinç, K., Leyla Acan, N., Saran, Y., & Turan, B. (2005). Selenium treatment protects diabetes-induced biochemical and ultrastructural alterations in liver tissue. Biological Trace Element Research, 105, 135–150.10.1385/BTER:105:1-3
   Google Scholar
• Da̧broś, W., Goc, A., Turyna, B., & Kordowiak, A. (2005). Sodium metavanadate affected control and streptozotocin-diabetic rat liver golgi complexes. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists, 57, 91–97.
   Google Scholar
• Dabroś, W., Kajda, B., & Kordowiak, A. M. (2001). Control and STZ-diabetic rat liver Golgi complexes under the influence of bis (2, 2′-bipyridine) oxovanadium (IV) sulphate. The morphological investigation. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists, 53, 123–128.
   Google Scholar
• Doi, K., Yamanouchi, J., Kume, E., & Yasoshima, A. (1997). Morphologic changes in hepatocyte nuclei of streptozotocin (SZ)-induced diabetic mice. Experimental and Toxicologic Pathology, 49, 295–299.10.1016/S0940-2993(97)80041-3
   Google Scholar
• Dowman, J. K., Tomlinson, J., & Newsome, P. (2010). Pathogenesis of non-alcoholic fatty liver disease. QJM, 103, 71–83.10.1093/qjmed/hcp158
   Google Scholar
• Elasha, H., Alzahrani, S., Almalki, M., Alomair, A., & Alshakweer, W. (2010). Acute hepatic steatosis: An unusual manifestation of poorly controlled type 1 diabetes. Practical Diabetes International, 27, 282–280a.10.1002/pdi.1503
   Google Scholar
• Evelson, P., Susemihl, C., Villarreal, I., Llesuy, S., Rodríguez, R., Peredo, H., … Filinger, E. (2005). Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Annals of Hepatology, 4, 115–120.
   Google Scholar
• Farrell, G. C., & Larter, C. Z. (2006). Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology, 43(S1), 99–112.
   Google Scholar
• Ferré, P., & Foufelle, F. (2007). SREBP-1c transcription factor and lipid homeostasis: Clinical perspective. Hormone Research in Paediatrics, 68, 72–82.10.1159/000100426
   Google Scholar
• Guven, A., Yavuz, O., Cam, M., Ercan, F., Bukan, N., Comunoglu, C., & Gokce, F. (2006). Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochemica, 108, 85–93.10.1016/j.acthis.2006.03.005
   Google Scholar
• Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002). SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of Clinical Investigation, 109, 1125–1131.10.1172/JCI0215593
   Google Scholar
• Junod, A., Lambert, A., Orci, L., Pictet, R., Gonet, A., & Renold, A. (1967). Studies of the diabetogenic action of streptozotocin. Experimental Biology and Medicine, 126, 201–205.10.3181/00379727-126-32401
   Google Scholar
• Kaneto, H., Nakatani, Y., Kawamori, D., Miyatsuka, T., Matsuoka, T.-A., Matsuhisa, M., & Yamasaki, Y. (2006). Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance. The International Journal of Biochemistry & Cell Biology, 38, 782–793.10.1016/j.biocel.2006.01.004
   Google Scholar
• Khan, Z. A., Farhangkhoee, H., & Chakrabarti, S. (2006). Towards newer molecular targets for chronic diabetic complications. Current Vascular Pharmacology, 4, 45–57.10.2174/157016106775203081
   Google Scholar
• Kozyritskiĭ, V., & Minchenko, A. (1977). Ultrastructural changes in rat hepatocytes with diabetes and insulin administration. TSitologiia i genetika, 12, 397–401.
   Google Scholar
• Kume, E., Ohmachi, Y., Itagaki, S.-I., Tamura, K., & Doi, K. (1994). Hepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes. Experimental and Toxicologic Pathology, 46, 368–374.10.1016/S0940-2993(11)80119-3
   Google Scholar
• Laguens, R., Candela, S., Hernández, R., & Gagliardino, J. (1980). Streptozotocin-induced liver damage in mice. Hormone and Metabolic Research, 12, 197–201.10.1055/s-2007-996241
   Google Scholar
• Leite, N. C., Villela-Nogueira, C. A., Pannain, V. L., Bottino, A. C., Rezende, G. F., Cardoso, C. R., & Salles, G. F. (2011). Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: Prevalences and correlated factors. Liver International, 31, 700–706.10.1111/liv.2011.31.issue-5
   Google Scholar
• Lenaerts, J., Verresen, L., Steenbergen, W., & Fevery, J. (1990). Fatty liver hepatitis and type 5 hyperlipoproteinemia in juvenile diabetes mellitus. Journal of Clinical Gastroenterology, 12, 93–97.10.1097/00004836-199002000-00024
   Google Scholar
• Lucchesi, A. N., Freitas, N. T. D., Cassettari, L. L., Marques, S. F. G., & Spadella, C. T. (2013). Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: A mechanism for diabetic chronic liver disease. Acta Cirurgica Brasileira, 28, 502–508.10.1590/S0102-86502013000700005
   Google Scholar
• Lucchesi, A. N., Cassettari, L. L., & Spadella, C. T. (2015). Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. Journal of Diabetes Research, 2015, 1–11.
   Google Scholar
• Mahmoud, A., & Al-Salahy, M. (2004). Physiological and histological studies on the effect of lupine seeds on the fish, clarias lazera treated with glucose and alloxan. Fish Physiology and Biochemistry, 30, 213–229.10.1007/s10695-005-8243-6
   Google Scholar
• Mendez-Sanchez, N., Chavez-Tapia, N., & Uribe, M. (2003). An update on non-alcoholic fatty liver disease. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 56, 72–82.
   Google Scholar
• Mifsud, S., Allen, T., Bertram, J., Hulthen, U., Kelly, D., Cooper, M., … Gilbert, R. (2001). Podocyte foot process broadening in experimental diabetic nephropathy: Amelioration with renin-angiotensin blockade. Diabetologia, 44, 878–882.
   Google Scholar
• Obineche, E., Mensah-Brown, E., Chandranath, S., Ahmed, I., Naseer, O., & Adem, A. (2001). Morphological changes in the rat kidney following long-term diabetes. Archives of Physiology and Biochemistry, 109, 241–245.10.1076/apab.109.3.241.11592
   Google Scholar
• Portincasa, P., Grattagliano, I., Palmieri, V. O., & Palasciano, G. (2005). Nonalcoholic steatohepatitis: Recent advances from experimental models to clinical management. Clinical Biochemistry, 38, 203–217.10.1016/j.clinbiochem.2004.10.014
   Google Scholar
• Postic, C., Burcelin, R., Rencurel, F., Pegorier, J.-P., Loizeau, M., Girard, J., & Leturque, A. (1993). Evidence for a transient inhibitory effect of insulin on GLUT2 expression in the liver: Studies in vivo and in vitro. Biochemical Journal, 293, 119–124.10.1042/bj2930119
   Google Scholar
• Regnell, S. E., & Lernmark, A. (2011). Hepatic steatosis in type 1 diabetes. The Review of Diabetic Studies, 8, 454–467.10.1900/RDS.2011.8.454
   Google Scholar
• Remedio, R. N., Castellar, A., Barbosa, R. A., Gomes, R. J., & Caetano, F. H. (2011). Morphology and protein content of hepatocytes in type I diabetic rats submitted to physical exercises. Micron, 42, 484–491.10.1016/j.micron.2011.01.008
   Google Scholar
• Roskams, T., Yang, S. Q., Koteish, A., Durnez, A., DeVos, R., Huang, X., … Diehl, A. M. (2003). Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. The American Journal of Pathology, 163, 1301–1311.10.1016/S0002-9440(10)63489-X
   Google Scholar
• Saltiel, A. R., & Kahn, C. R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414, 799–806.10.1038/414799a
   Google Scholar
• Smith, B. W., & Adams, L. A. (2011). Nonalcoholic fatty liver disease and diabetes mellitus: Pathogenesis and treatment. Nature Reviews Endocrinology, 7, 456–465.10.1038/nrendo.2011.72
   Google Scholar
• Thakran, S., Siddiqui, M., & Baquer, N. Z. (2004). Trigonella foenum graecum seed powder protects against histopathological abnormalities in tissues of diabetic rats. Molecular and Cellular Biochemistry, 266, 151–159.10.1023/B:MCBI.0000049153.14295.0d
   Google Scholar
• Thorens, B., Sarkar, H. K., Kaback, H. R., & Lodish, H. F. (1988). Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell, 55, 281–290.10.1016/0092-8674(88)90051-7
   Google Scholar
• Verderese, J. P., & Younossi, Z. (2013). Interaction of Type 2 diabetes and nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology, 7, 405–407.10.1586/17474124.2013.811047
   Google Scholar
• Vergès, B. (2009). Lipid disorders in type 1 diabetes. Diabetes & Metabolism, 35, 353–360.10.1016/j.diabet.2009.04.004
   Google Scholar
• Voss, C., Brachmann, K., & Hartmann, K. (1988). Effect of streptozotocin on transaminases, creatinine and urea in serum of rats. Experimental and Clinical Endocrinology & Diabetes, 92, 37–42.10.1055/s-0029-1210779
   Google Scholar
• Weickert, M., & Pfeiffer, A. (2006). Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia, 49, 1732–1741.10.1007/s00125-006-0295-3
   Google Scholar
• Welt, K., Weiss, J., Martin, R., Dettmer, D., Hermsdorf, T., Asayama, K., … Fitzl, G. (2004). Ultrastructural, immunohistochemical and biochemical investigations of the rat liver exposed to experimental diabetes und acute hypoxia with and without application of Ginkgo extract. Experimental and Toxicologic Pathology, 55, 331–345.10.1078/0940-2993-00337
   Google Scholar
• Wigg, A., Roberts-Thomson, I., Dymock, R., McCarthy, P., Grose, R., & Cummins, A. (2001). The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut, 48, 206–211.10.1136/gut.48.2.206
   Google Scholar
• Yamashita, H., Takenoshita, M., Sakurai, M., Bruick, R. K., Henzel, W. J., Shillinglaw, W., … Uyeda, K. (2001). A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proceedings of the National Academy of Sciences, 98, 9116–9121.10.1073/pnas.161284298
   Google Scholar
• Yang, S. Q., Lin, H. Z., Mandal, A. K., Huang, J., & Diehl, A. M. (2001). Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology. Hepatology, 34, 694–706.10.1053/jhep.2001.28054
   Google Scholar